Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Moritz F. Jäger,CTO of Northern Bitcoin
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Northern Bitcoin
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Exploring Mining Innovation: A Conversation with NSS Canada's Bruno Lalonde | Bruno Lalonde - CEO/President of NSS Canada
00:10:00
African Gold Group: Kabada Project Advancements and Exploration Upside in Southern Mali
00:10:00
Florida with an intentionally inclusive investment thesis|Ann E. Metzger,General Partner,360 Venture Collective
00:10:00
Octava Minerals: Advancing Lithium, Gold, and Nickel Projects in Western Australia
00:10:00
A Business Founded on a Simple and Powerful Model|Kenneth M. Jacobs,Executive Chairman,Lazard Group LLC
00:10:00
Paul Henrietti Reflects on Sanlam's Challenges and Future Amidst Global Turbulence | Paul Hanratty, CEO, Sanlam.
00:10:00
"At Belden, regardless of career stage, thrive in an environment fostering support, continuous professional growth, and exploration of potential."|David Aldrich is Director and Chair of the Board of Belden Inc
00:10:00
Charitable Giving Workshop: Developing Your Philanthropic Plan | DANA BREWER - Principal - Financial Advisor of Birchwood Financial Partners, Inc.
00:00:00
AirXpanders Inc.(ASX:AXP) sales and product update - Scott Dodson, CEO,AirXpanders Inc
00:00:00
Maziyar A. Kalani, M.D. Neurosurgeon, Mayo Clinic / Minimally Invasive Spine Surgery
00:00:00
Kathleen Skarvan, CEO, Electromed Inc
00:10:00
The video outlines Axiom's views, emphasizing their potential for change, the risks of investment, and that statements made are for informational purposes only and not guarantees of future performance.